SCHEMBL23837503

SCHEMBL23837503

CC(=O)CCC(O)N[C@H]1Cc2cc(Cl)c(Cl)c(C(=O)O)c2OB1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17347778 0.84 — —
SCHEMBL17347833 0.81 CAT (0.30) —
SCHEMBL17347653 0.78 MTNR1A (0.33) —
SCHEMBL17347791 0.78 MTNR1A (0.30) —
SCHEMBL23130239 0.78 MTNR1A (0.30) —
SCHEMBL19662954 0.73 — —
SCHEMBL17347939 0.70 — —
SCHEMBL17347820 0.70 OPRK1 (0.34) —
SCHEMBL23130252 0.70 OPRK1 (0.34) —
SCHEMBL23837357 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback